ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES
Live / Registered — Registered (as of 18 Jun 2024)
What this means for you
Registered since 18 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97693879
- Registration number
- 7423244
- Mark type
- Design + words
- Filed
- 28 Nov 2022
- Published for opposition
- 08 Aug 2023
- Registered
- 18 Jun 2024
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 035 — Advertising and business services: Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support program for facilitating access to, distribution of, and reimbursement for pharmaceutical products
- Class 036 — Insurance and financial services: Providing health insurance information about health insurance benefits, medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance to patients; financial consultation to medical patients in identification of health insurance alternatives; providing patient assistance programs, namely, providing financial assistance programs to provide access to pharmaceutical preparations at low or no cost to qualified uninsured and underinsured patients who have a demonstrated financial need
- Class 044 — Medical, beauty and agricultural services: Informational counseling for patients, namely, providing information and assistance with respect to obtaining prescription medications for medical purposes
Owner
- ImmunoGen, Inc., Waltham, MA, US
- ImmunoGen, Inc., Waltham, MA, US
- ImmunoGen, Inc., Waltham, MA, US
Prosecution history
- 18 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Mar 2024 — USE AMENDMENT FILED
- 01 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 08 Mar 2024 — SOU EXTENSION 1 GRANTED
- 08 Mar 2024 — SOU EXTENSION 1 FILED
- 08 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Oct 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Aug 2023 — PUBLISHED FOR OPPOSITION